Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones

Anesth Analg. 2003 Aug;97(2):494-505. doi: 10.1213/01.ANE.0000059225.40049.99.

Abstract

Indirect evidence indicates that morphine-3-glucuronide (M3G) may contribute significantly to the neuro-excitatory side effects (myoclonus and allodynia) of large-dose systemic morphine. To gain insight into the mechanism underlying M3G's excitatory behaviors, we used fluo-3 fluorescence digital imaging techniques to assess the acute effects of M3G (5-500 microM) on the cytosolic calcium concentration ([Ca(2+)](CYT)) in cultured embryonic hippocampal neurones. Acute (3 min) exposure of neurones to M3G evoked [Ca(2+)](CYT) transients that were typically either (a) transient oscillatory responses characterized by a rapid increase in [Ca(2+)](CYT) oscillation amplitude that was sustained for at least approximately 30 s or (b) a sustained increase in [Ca(2+)](CYT) that slowly recovered to baseline. Naloxone-pretreatment decreased the proportion of M3G-responsive neurones by 10%-25%, implicating a predominantly non-opioidergic mechanism. Although the naloxone-insensitive M3G-induced increases in [Ca(2+)](CYT) were completely blocked by N-methyl-D-aspartic acid (NMDA) antagonists and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate antagonist), CNQX did not block the large increase in [Ca(2+)](CYT) evoked by NMDA (as expected), confirming that M3G indirectly activates the NMDA receptor. Additionally, tetrodotoxin (Na(+) channel blocker), baclofen (gamma-aminobutyric acid(B) agonist), MVIIC (P/Q-type calcium channel blocker), and nifedipine (L-type calcium channel blocker) all abolished M3G-induced increases in [Ca(2+)](CYT), suggesting that M3G may produce its neuro-excitatory effects by modulating neurotransmitter release. However, additional characterization is required.

Implications: Large systemic doses of morphine administered to some patients for cancer pain management have been reported to produce myoclonus and allodynia. Indirect evidence implicates the major morphine metabolite, morphine-3-glucuronide (M3G), in these neuro-excitatory side effects. Hence, this study was designed to gain insight into the cellular mechanism responsible for M3G's neuro-excitatory actions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Aniline Compounds
  • Animals
  • Baclofen / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Cells, Cultured
  • Central Nervous System Stimulants / pharmacology*
  • Cytosol / metabolism
  • Excitatory Amino Acid Antagonists / pharmacology
  • Fluorescent Dyes
  • GABA Agonists / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Image Processing, Computer-Assisted
  • Immunohistochemistry
  • Microscopy, Fluorescence
  • Morphine Derivatives / pharmacology*
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Tetrodotoxin / pharmacology
  • Xanthenes

Substances

  • Aniline Compounds
  • Calcium Channel Blockers
  • Central Nervous System Stimulants
  • Excitatory Amino Acid Antagonists
  • Fluorescent Dyes
  • GABA Agonists
  • Morphine Derivatives
  • Narcotic Antagonists
  • Receptors, N-Methyl-D-Aspartate
  • Xanthenes
  • Fluo-3
  • Naloxone
  • Tetrodotoxin
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • Baclofen
  • morphine-3-glucuronide
  • Calcium